MedPath

Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation

Not Applicable
Recruiting
Conditions
Hand
Stroke
Rehabilitation
Interventions
Device: transcranial direct current stimulation and electrical stimulator
Registration Number
NCT03857529
Lead Sponsor
MetroHealth Medical Center
Brief Summary

This pilot study for stroke patients with chronic upper limb hemiplegia will examine the effects of non-invasive brain stimulation and neuromuscular electrical stimulation on hand motor control and corticospinal excitability. Specifically, this study will investigate the effects of timing and delivery of tDCS in conjunction with contralaterally controlled functional electrical stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  1. Age ≥ 21

  2. ≥ 6 months since first clinical hemorrhagic or nonhemorrhagic stroke

  3. Able to follow 3-stage commands and remember 2 of 3 items after 30 minutes

  4. Full volitional elbow extension/flexion and hand opening/closing of unaffected limb

  5. Adequate active movement of shoulder and elbow to position the paretic hand in the workspace for table-top task practice

  6. Patient must be able to sit unassisted in an armless straight-back chair for the duration of the screening portion of the eligibility assessment

  7. Medically stable

  8. ≥ 10° finger extension

  9. Unilateral upper limb hemiparesis with finger extensor strength of ≤ grade 4/5 on the manual muscle test AND a score of

    ≥1 and ≤ 11/14 on the hand section of the upper extremity Fugl-Meyer Assessment

  10. Skin intact on hemiparetic arm, hand and scalp

  11. While relaxed, surface neuromuscular electrical stimulation of finger extensors and thumb extensors and/or abductors produces a functional degree of hand opening without pain.

  12. No significant visual or hearing impairment

Exclusion Criteria
  1. Co-existing neurological condition other than prior stroke involving the hemiparetic upper limb (e.g., peripheral nerve injury, Parkinson's disease, spinal cord injury, traumatic brain injury, multiple sclerosis).
  2. Uncontrolled seizure disorder
  3. Use of seizure lowering threshold medications at the discretion of the study physician (Dr. Rich Wilson)
  4. Cardiac pacemaker or other implanted electronic device and/or stent
  5. Pregnant
  6. Intramuscular botox injections in any upper extremity muscle in the last 3 months
  7. Insensate arm, forearm, or hand
  8. Severely impaired cognition and communication
  9. Uncompensated hemi-neglect (extinguishing to double simultaneous stimulation)
  10. Severe shoulder or hand pain (unable to position hand in the workspace without pain)
  11. Metal implant in the head

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
unconventional tDCS concurrent with CCFEStranscranial direct current stimulation and electrical stimulatortDCS cathode placed over the lesioned hemisphere and anode placed over the non-lesioned hemisphere
conventional tDCS concurrent with CCFEStranscranial direct current stimulation and electrical stimulatortDCS anode placed over the lesioned hemisphere and cathode placed over the non-lesioned hemisphere
conventional tDCS preceding CCFEStranscranial direct current stimulation and electrical stimulatortDCS anode placed over the lesioned hemisphere and cathode placed over the non-lesioned hemisphere
unconventional tDCS preceding CCFEStranscranial direct current stimulation and electrical stimulatortDCS cathode placed over the lesioned hemisphere and anode placed over the non-lesioned hemisphere
sham tDCS with CCFEStranscranial direct current stimulation and electrical stimulatorsham tDCS preceding and concurrent with CCFES
Primary Outcome Measures
NameTimeMethod
Corticospinal Excitabilityup to one hour post intervention

Change in corticospinal excitability will be measured with transcranial magnetic stimulation

Reaction Timeup to one hour post intervention

Change in reaction time will be assessed with visual and auditory cues.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MetroHealth Medical Center

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath